fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Should GLP-1 agonists should be used earlier in type 2 diabetes?

Written by | 27 Sep 2023

In the future, GLP-1 agonists could be used early in treatment for type II diabetes and this could have an important impact on slowing the onset of complications,… read more.

How GLP-1 agonists help in type 2 diabetes

Written by | 26 Sep 2023

GLP-1 agonists such as semaglutide were developed for treatment of type II diabetes but have also been successful as weight-loss agents for non-diabetics. Many new agents are now… read more.

Removing incorrect penicillin allergy labels in a UK hospital

Written by | 25 Aug 2023

Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a pilot study has shown that a pharmacy-led multidisciplinary team can… read more.

Outcomes of penicillin allergy de-labelling

Written by | 24 Aug 2023

A total of 56 patients were successfully de-labelled in the pilot study but a key challenge will be preventing the erroneous reappearance of the penicillin allergy label, according… read more.

Why should we de-label ‘penicillin-allergic’ patients?

Written by | 23 Aug 2023

Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a recent publication has shown that a pharmacy-led multidisciplinary team can… read more.

The European Society for Clinical Pharmacy (ESCP) – developments and aspirations

Written by | 14 Aug 2023

‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023.  In this… read more.

How the Oath to Society underpins clinical pharmacy practice

Written by | 13 Aug 2023

The Oath to Society, jointly developed by ESCP and EAHP underpins clinical pharmacy services and highlights pharmacists’ work to those outside the profession, according to ESCP President, Professor… read more.

Building best practice in clinical pharmacy

Written by | 12 Aug 2023

ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.

How ESCP special interest groups forge worldwide links

Written by | 11 Aug 2023

ESCP is a dynamic organisation that responds to the needs of its members and in doing so it has undertaken a number of key developments in recent years,… read more.

Why join the European Society for Clinical Pharmacy?

Written by | 10 Aug 2023

‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023.  IMI spoke… read more.

Pharmacogenomics and personalised medicine in practice

Written by | 29 Jul 2023

Pharmacogenomics and personalised medicine are increasingly becoming a part of mainstream healthcare and it is an area where pharmacists have a major part to play. In this series… read more.

The challenges of developing pharmacogenomic services

Written by | 28 Jul 2023

Recent research has demonstrated the value of pharmacogenomics-guided prescribing but this is a far cry from the implementation of routine services. Dr Raliate Onatade Chief Pharmacist for North… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.